Veterans PTSD Clinical Research Amendments

HB 390 authorizes Utah's Huntsman Mental Health Institute to conduct a clinical study on the safety and feasibility of psychedelic-assisted therapy for veterans with treatment-resistant PTSD (veterans whose PTSD hasn't improved with standard treatments). The bill permits Huntsman to accept donations and grants to fund the study, requiring combined legislative appropriations and donations to reach a sufficient threshold by January 1, 2027, to begin the research. Huntsman must report findings to the Health and Human Services Interim Committee and will return unused donations by July 1, 2032. The study must comply with federal and state regulations, including FDA oversight and safety protocols for administering psychedelic drugs like MDMA or psilocybin in controlled settings. The bill makes no direct funding appropriation and focuses solely on enabling this specific research initiative.